Maternal recall of hypertensive disorders in pregnancy: A systematic review

Journal of Women's Health

Volumn 22, Issue 1, 2013, Pages 37-47

  Stuart, Jennifer J ^a,b   Noel Bairey Merz, C ^c   Berga, Sarah L ^d   Miller, Virginia M ^e   Ouyang, Pamela ^f   Shufelt, Chrisandra L ^c   Steiner, Meir ^g   Wenger, Nanette K ^h   Rich Edwards, Janet W ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e MAYO CLINIC   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MCMASTER UNIVERSITY   (Canada)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; EDUCATIONAL STATUS; HUMAN; MATERNAL HYPERTENSION; MATERNAL RECALL; MEDICAL HISTORY; MEDICAL RECORD; PARITY; PREDICTIVE VALUE; PREECLAMPSIA; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECALL; REVIEW; SELF REPORT; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84872340118     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.3740     Document Type: Review

References (50)

1. World Health Organization. Preventing chronic disease: A vital investment. WHO Press. Available at www.who.int/chp/chronic-disease-report/ contents/en/index.html Accessed July 8, 2011.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association. Heart disease and stroke statistics-2012 update. Circulation 2012;125:e2-e220.
3. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-2645.
4. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
5. Centers for Disease Control and Prevention. Trends in cholesterol screening and awareness of high blood cholesterol: United States,1991-2003. MMWR 2005;54:865-870.
6. Antikainen RL, Moltchanov VA, Chukwuma C Sr, et al. Trends in the prevalence, awareness, treatment and control of hypertension: The WHO MONICA Project. Eur J Cardiovasc Prev Rehabil 2006;13:13-29.
7. National Institutes of Health. State-of-the-Science conference statement: Tobacco use: prevention, cessation, and control. Ann Intern Med 2006;145:839-844.
8. Gregg EW, Cheng YJ, Cadwell BL, et al. Secular trends in cardiovascular disease risk factors according to body mass index in U.S. adults. JAMA 2005;293:1868-1874.
9. Mozaffarian D, Wilson PWF, Kannel WB. Beyond established and novel risk factors: Lifestyle risk factors for cardiovascular disease. Circulation 2008;117:3031-3038.
10. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;290:898-904.
11. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003;290:891-897.
12. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
13. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005;111:3481-3488.
14. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women. JAMA 2007;297: 611-619.
15. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ 2007; 335:974.
16. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses. Am Heart J 2008;156: 918-30.
17. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after preeclampsia: Population based cohort study. BMJ 2001;323:1213-1217.
18. Smith G, Whitley E, Gissler E, Hemminki E. Birth dimensions of offspring, premature birth, and the mortality of the mothers. Lancet 2000;336:2066-2067.
19. Smith GD, Sterne J, Tynelius P, Lawlor DA, Rasmussen F. Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology 2005;16:563-569.
20. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: Opportunities for intervention and screening? BMJ 2002;325:157-160.
21. Rich-Edwards JW. Reproductive health as a sentinel of chronic disease in women. Womens Health (Lond) 2009;5:101-105.
22. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin J-M. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:ix-xiv.
23. Diagnosis and management of preeclampsia and eclampsia. ACOG Committee on Obstetric Practice. ACOG practice bulletin. No. 33, January 2002. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:159-167.
24. Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: A nationwide sample of delivery admissions. Am J Obstet Gynecol 2011;206:1.e1-1.e8.
25. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who develop hypertension. Obstet Gynecol 2000;95:24-28.
26. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Intensification of fetal and maternal surveillance in pregnant women with hypertensive disorders. Int J Gynecol Obstet 1998;61:127-133.
27. Sibai BM, Caritis SN, Thom E, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1993;329:1213-1219.
28. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: A prospective multicenter study. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995;172:642-648.
29. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181-192.
30. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? Br J Obstet Gynaecol 2004;111:298-302.
31. Maynard SE, Karumanchi SA, Thadhani R. Hypertension and kidney disease in pregnancy. In: Brenner BM, ed. Brenner & Rector's the kidney, 8th ed. Philadelphia: Saunders, 2008:1567-1595.
32. Magee LA, Ornstein MP, von Dadelszen P. Management of hypertension in pregnancy. BMJ 1999;318:1332-1336.
33. Chronic hypertension in pregnancy. ACOG practice bulletin. No. 29. American College of Obstetricians and Gynecologists. Obstet Gynecol 2001;98:177-185.
34. Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338: 701-705.
35. Rich-Edwards JW, McElrath TF, Karumanchi SA, Seely EW. Breathing life into the lifecourse approach: Pregnancy history and cardiovascular disease in women. Hypertension 2010;56:331-334.
36. Olson JE, Shu XO, Ross JA, et al. Medical record validation of maternally reported birth characteristics and pregnancyrelated events: A report from the Children's Cancer Group. Am J Epidemiol 1997;145:58-67.
37. Klemmensen AK, Olsen SF, Osterdal ML, Tabor A. Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am J Epidemiol 2007;166:117-124.
38. Coolman M, de Groot CJM, Jaddoe VW, et al. Medical record validation of maternally reported history of preeclampsia. J Clin Epidemiol 2010;63:932-937.
39. Delgado-Rodriguez M, Gomez-Olmedo M, Bueno-Cavanillas A, et al. Recall bias in a case-control study of low birth weight. J Clin Epidemiol 1995;48:1133-1140.
40. Sou SC, Chen WJ, Hsieh WS, Jeng SF. Severe obstetric complications and birth characteristics in preterm or term delivery were accurately recalled by mothers. J Clin Epidemiol 2006;59:429-435.
41. Walshe M, McDonald C, Boydell J, et al. Long-term maternal recall of obstetric complications in schizophrenia research. Psychiatry Res 2011;187:335-340.
42. Buka SL, Goldstein JM, Seidman LJ, et al. Maternal recall of pregnancy history: Accuracy and bias in schizophrenia research. Schizophr Bull 2000;26:335-350.
43. Buka SL, Goldstein JM, Spartos E, et al. The retrospective measurement of prenatal and perinatal events: Accuracy of maternal recall. Schizophr Res 2004;71:417-426.
44. Diehl CL, Brost BC, Hogan MC, et al. Preeclampsia as a risk factor for cardiovascular disease later in life: Validation of a preeclampsia questionnaire. Am J Obstet Gynecol 2008;198: e11-13.
45. Jurek AM, Greenland S, Spector LG, Roseler MA, Robison LL, Ross JA. Self-report versus medical record-Perinatal factors in a study of infant leukemia: A study from the Children's Oncology Group. Paediatr Perinat Epidemiol 2011;25:540-548.
46. Buka SL, Goldstein JM, Tsuang MT. "The measurement of fetal events in schizophrenia research." Paper presented at the American Psychiatric Association Symposium on Fetal Brain Development in Schizophrenia, San Francisco, CA, May 1989.
47. Sibai BM. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1eS22.
48. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
49. Young B, Hacker MR, Rana S. Physicians' knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy 2012;31:50-58.
50. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A guideline from the American Heart Association. Circulation 2011;57:1404-1423.